Roivant Sciences (ROIV) Invested Capital (2022 - 2024)

Roivant Sciences' Invested Capital history runs 3 years deep, the most recent figure standing at $40.0 million for Q2 2024.

• Quarterly Invested Capital changed 0.0% year-over-year to $40.0 million in Q2 2024, while the trailing twelve-month figure through Mar 2025 was $40.0 million (down 91.4% YoY) and the FY2024 annual result came in at $40.0 million, changed 0.0% from the prior year.
• Invested Capital was $40.0 million for Q2 2024 at Roivant Sciences, roughly flat from $40.0 million in the prior quarter.
• Across five years, Invested Capital topped out at $195.3 million in Q4 2023 and bottomed at $7.3 million in Q2 2022.
• A 3-year average of $80.0 million and a median of $40.0 million in 2022 frame the typical range for Invested Capital.
• Peak annual rise in Invested Capital reached 444.66% in 2023, while the deepest fall reached 0.0% in 2023.
• Roivant Sciences' Invested Capital stood at $40.0 million in 2022, then surged by 388.24% to $195.3 million in 2023, then slumped by 79.52% to $40.0 million in 2024.
• Business Quant data shows ROIV's Invested Capital at $40.0 million in Q2 2024, $40.0 million in Q1 2024, and $195.3 million in Q4 2023.